Lumisys issues warning on second-quarter results

Article

Lumisys issues warning on second-quarter resultsFilm digitizer firm Lumisys warned that its second-quarter bookings have not been as strong as anticipated, and the firm will have lower revenues during its second quarter. It is expected that

Lumisys issues warning on second-quarter results

Film digitizer firm Lumisys warned that its second-quarter bookings have not been as strong as anticipated, and the firm will have lower revenues during its second quarter. It is expected that earnings, scheduled for release after the market closes on July 9, will be break-even to slightly positive for the period, said Craig Klosterman, COO and CFO.

Continuing to believe its stock is undervalued, the Lumisys board of directors has authorized an additional repurchase of 500,000 shares of its common stock. Lumisys repurchased 350,000 shares of common stock during the second quarter as part of an earlier stock buyback program.

In product news, Lumisys has released DICOM-compatible interface software, which can be incorporated across the company's entire family of Lumiscan film digitizers. The Windows NT-based interface, called DI-2000, generates DICOM 3.0 output of images, and provides support for DICOM 3.0 storage class user, storage class provider, and query/retrieve. It also supports lossless, lossy, and enhanced JPEG compression, as well as image transmission over a local area network, wide area network, or the Internet, according to the company. Royalty-free software will be provided to all trained and certified integrators and OEMs incorporating Lumisys digitizers into PACS and teleradiology networks, according to the Sunnyvale, CA-based company.

Recent Videos
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
What New Research Reveals About the Impact of AI and DBT Screening: An Interview with Manisha Bahl, MD
Can AI Assessment of Longitudinal MRI Scans Improve Prediction for Pediatric Glioma Recurrence?
A Closer Look at MRI-Guided Adaptive Radiotherapy for Monitoring and Treating Glioblastomas
Incorporating CT Colonography into Radiology Practice
What New Research Reveals About Computed Tomography and Radiation-Induced Cancer Risk
What New Interventional Radiology Research Reveals About Treatment for Breast Cancer Liver Metastases
New Mammography Studies Assess Image-Based AI Risk Models and Breast Arterial Calcification Detection
Can Deep Learning Provide a CT-Less Alternative for Attenuation Compensation with SPECT MPI?
Employing AI in Detecting Subdural Hematomas on Head CTs: An Interview with Jeremy Heit, MD, PhD
Related Content
© 2025 MJH Life Sciences

All rights reserved.